Allergan plc announced a national education campaign called My Glaucoma.

Allergan plc announced the launch of three new over-the-counter (OTC) REFRESH® RELIEVA™ products.

Allergan plc and Molecular Partners, a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, announced two-year data from the CEDAR and SEQUOIA clinical studies of investigational Abicipar in patients with neovascular (wet) age-related macular degeneration (nAMD).

Allergan plc will present new data from investigational Abicipar and Bimatoprost Sustained Release (SR) at the Annual Meeting of the American Academy of Ophthalmology (AAO) to be held in San Francisco, California.

Women In Optometry releases full coverage of its inaugural leadership summit.